---
figid: PMC12133868__fonc-15-1598934-g002
figtitle: ' MAPK signaling pathway'
organisms:
- NA
organisms_ner:
- Danio rerio
- Homo sapiens
pmcid: PMC12133868
filename: fonc-15-1598934-g002.jpg
figlink: /pmc/articles/PMC12133868/figure/F2/
number: F2
caption: (A) MAPK signaling pathway. This pathway binds to growth factors and receptor
  tyrosine kinase RTK, thereby activating the phosphorylation cascade of RAS, BRAF,
  MEK, and ERK. (B) RAS activation subsequently initiates downstream signaling cascades,
  predominantly the Raf-MAPK and PI3K-AKT pathways
papertitle: Application and recent advances in conventional biomarkers for the prognosis
  of papillary thyroid carcinoma
reftext: Muzi Li, et al. Front Oncol. 2025;15(NA).
year: '2025'
doi: 10.3389/fonc.2025.1598934
journal_title: Frontiers in Oncology
journal_nlm_ta: Front Oncol
publisher_name: Frontiers Media SA
keywords: papillary thyroid carcinoma | BRAF V600E | TERT | Ras | CD147 | tumor microenvironment
  | ctDNA | microRNA
automl_pathway: 0.9447347
figid_alias: PMC12133868__F2
figtype: Figure
redirect_from: /figures/PMC12133868__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC12133868__fonc-15-1598934-g002.html
  '@type': Dataset
  description: (A) MAPK signaling pathway. This pathway binds to growth factors and
    receptor tyrosine kinase RTK, thereby activating the phosphorylation cascade of
    RAS, BRAF, MEK, and ERK. (B) RAS activation subsequently initiates downstream
    signaling cascades, predominantly the Raf-MAPK and PI3K-AKT pathways
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ret
  - rab1ab
  - braf
  - si:dkey-222f8.3
  - hrasa
  - kras
  - nras
  - tsc2
  - mtor
  - badb
  - chmp2a
  - RET
  - F9
  - TAS2R38
  - PTCH1
  - CCDC6
  - KRAS
  - HRAS
  - NRAS
  - BRAF
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - EPHB2
  - MAPK1
  - MAPK3
  - ZHX2
  - ARAF
  - RAF1
  - AKT1
  - AKT2
  - AKT3
  - TSC2
  - MTOR
  - CANX
  - TFRC
  - CIP2A
  - CCDC8
  - BAD
  - BCL2
  - PTC
  - RAS
  - MEK
  - carcinoma
---
